Ocular administration of immunosuppressive agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070082841A1
SERIAL NO

11528840

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and systems for preventing or treating various ocular conditions are disclosed and described. In one aspect, for example, a method for minimizing systemic exposure to a steroid-sparing immunosuppressive agent during treatment or prevention of an ocular condition is provided. Such a method may include administering a steroid-sparing immunosuppressive agent directly into an eye of a subject having or at risk for having the ocular condition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ACIONT INC350 WEST 800 NORTH #320 SALT LAKE CITY UT 84103

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Delmage, Michael Napa, CA 3 170
Higuchi, John W Salt Lake City, UT 20 173
Kochambilli, Rajan Salt Lake City, UT 1 38
Mufson, Daniel Napa, CA 24 1938
Tuitupou, Anthony Salt Lake City, UT 2 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation